okbet88

okbet88 Published 23:53 IST, December 29th 2024 ISRO's Space Docking Experiment onboard a PSLV rocket that would be a key milestone in India's space programme will begin on Monday Sriharikota: The countdown for ISRO's Space Docking Experiment onboard a PSLV rocket on Monday that would be a key milestone in India's space programme, commenced on Sunday evening, the space agency said. A cost-effective technology demonstrator mission for in-space docking, it would make India join an elite list featuring China, Russia and the US. ISRO has scheduled the lift-off of the PSLV-C60 rocket, at 9.58 pm from the first launch pad at this spaceport here on December 30 and it would carry SpaDeX with two spacecraft as the primary payloads along with 24 secondary payloads. "PSLV-C60/SpaDeX Mission Launch countdown commenced at 9 pm" on Sunday, an ISRO official told PTI. The in-space docking technology would be essential for taking up India's ambitions in space including sending human to the Moon, bringing samples from there, and also building and operating India's own space station- Bharatiya Antariksh Station. The docking technology would also be utilised when multiple rocket launches are planned to achieve common mission objectives. ISRO said the two spacecraft in the PSLV rocket-- Spacecraft A (SDX01) and Spacecraft B (SDX02) would be placed in an orbit that would keep them 5 km apart from each other. Later, scientists at ISRO headquarters would try to bring them closer up to 3 metre which would subsequently lead them for merging together at an altitude of about 470km above Earth. The process is expected to take place about 10-14 days after the scheduled lift-off on Monday, ISRO officials said. In the SpaDeX mission, Spacecraft A carries a High Resolution Camera, while Spacecraft B has Miniature Multispectral Payload and a Radiation Monitor Payload. These payloads would provide high resolution images, natural resource monitoring, vegetation studies among others. Apart from this significant mission, scientists would also conduct the PSLV Orbital Experimental Module-4 (POEM-4) in which 24 payloads--14 from ISRO and 10 from industry and academia, would be placed in the desired orbits one after the other over a 90 minute period after the lift-off. The life of the payloads in the fourth stage would be about three to four months. The vehicle for the PSLV-C60 mission used here would be the 18th Core-Alone variant. This would be ISRO's last mission in 2024 and the PSLV-C60 is the first vehicle to be integrated upto the fourth stage at the PSLV Integration Facility that has been established here. Updated 23:53 IST, December 29th 2024PHILADELPHIA (WPVI) -- It was an announcement that took the world by surprise: South Korea's president declaring a state of martial law. Within hours, he was forced to rescind that order, but not before chaos broke out. Among the people watching the drama unfold is a New Jersey lawmaker who has deep family ties to South Korea. READ MORE: South Korean state council passes resolution lifting martial law "My parents and me and my sister, we're the only part of our family that's in the United States. The rest of our family is back in Korea," said United States Senator-Elect Andy Kim (D - New Jersey). He received messages with headlines of the martial law declaration by South Korean President Yoon Suk Yeol. It was something that, at first, he couldn't believe. "I could not imagine that there was a martial law declaration," said Kim who is the son of Korean immigrants. He was just as surprised as anyone on Tuesday. "It was surreal," said Kim. "It was really sad honestly when I started to understand what happened." SEE ALSO: South Korean president faces calls to resign after martial law lifted The sudden declaration opened the floodgates of protest and sent members of parliament scrambling to barricade themselves against soldiers as they voted against martial law. It forced Yoon to reverse course and rescind the order only about six hours after it was issued. One day later, Kim says, from what he understands, things in South Korea are still tense. "It seems like the threat of that martial law has subsided," said Kim, "but now there are continued questions about what comes next." "It has shaken the people," he said. Opposition leaders say Yoon's motivation in declaring martial law was political. Yoon is very unpopular in South Korea, which is a key U.S. ally. "I'm in regular touch with the White House. With the State Department, with senior leadership there," said Kim who has also reached out to his constituents who have loved ones in South Korea. U.S. officials say they were blindsided by the martial law declaration. There are now calls for Yoon to resign or be impeached. Kim thinks that at the heart of it all is a message on democracy. "You should not ever be able to go outside the bounds of democracy unless there's an absolute national security crisis of the utmost importance," said Kim. "To do something like this was just crazy, honestly."

A renowned entertainer and disc jockey, Deejay Nani has won big at the recently concluded first-ever Nigerian Deejays Award which took place in Abuja. Deejay Nani who was crowned with the prestigious honour of Professional Deejay Of The Year Award joined the list of others who were honoured for their contribution in raising the bar of entertainment in the country. He is one of the most popular deejays in the city of Abuja who has over the years paid his dues in the industry. DJ Nani has played in high profile events within and outside the nation’s capital and brings a new aura that will spur enthusiasm among guests. His skills and ability to read the mood of guests at every event and give them suitable tunes is his key strength among his peers in the industry. Speaking at the event, the National President of Deejay Association of of Nigeria (DJAN), Mr. Christian Onyebuchi Mwatuegbe known by the stage name, DJ Perfect expressed satisfaction that the ceremony, despite being the first edition, turned out extremely successful and in the lifetime of his administration as the president. He expressed gratitude to his colleagues in the industry across the country for their support which culminated into the success recorded. Highlighting the role of deejays in our social life, he said, “DJ’s are the most essential part of any occasion as their absence will make any occasion boring and unenjoyable. “The DJs through their music add so much substance and vigour to any occasion no matter the events. Hence, we thought it wise to gather here today to give honour to whom honour is due and to celebrate ourselves in special dimension,” DJ Perfect said. For his own part, the Project Consultant and the CEO of Leadership Scorecard Magazine, Mr. Humphrey Onyima expressed happiness that deejays have come to recognise their crucial roles in the society which necessitated the award of recognition. He said, “Today is indeed a great day in the lives of members of Djan nationwide. Today’s awardees are men and women of caliber who have contributed immeasurably towards the growth of Deejaying in Nigeria.” Notable DJs at event include DJs Neptune, the legendary American DJ Dona Dee, cool, Humility, grande fingers,symptoms, Vicky Lee, Benny G, Stan, Valakan, Burna , Scratch, Baby gold, Ceekk, John, Matrix, DJ Trish and so much more.

ATLANTA , Dec. 12, 2024 /PRNewswire/ -- Cousins Properties Incorporated (the "Company" or "Cousins") (NYSE: CUZ ) announced today that its operating partnership, Cousins Properties LP (the "Operating Partnership"), has priced an offering of $400 million aggregate principal amount of 5.375% senior unsecured notes due 2032 at 99.463% of the principal amount. The offering is expected to close on December 17, 2024 , subject to the satisfaction of customary closing conditions. Cousins intends to use the net proceeds from the offering to fund a portion of the purchase price of 601 West 2nd Street, also known as Sail Tower, an 804,000 square foot trophy lifestyle office property in Austin (the "Sail Tower Acquisition"), and the remainder to repay borrowings under its credit facility and for general corporate purposes. In the event the Sail Tower Acquisition is not completed, Cousins will use the net proceeds from the offering for general corporate purposes, including the acquisition and development of office properties, other opportunistic investments and the repayment of debt. The notes will be fully and unconditionally guaranteed on a senior unsecured basis by the Company. J.P. Morgan, Truist Securities, US Bancorp, BofA Securities, Morgan Stanley, PNC Capital Markets LLC, TD Securities and Wells Fargo Securities are acting as joint book-running managers. A shelf registration statement relating to these securities is effective with the Securities and Exchange Commission. The offering may be made only by means of a prospectus supplement and accompanying prospectus. Copies of these documents may be obtained by contacting J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York , 10179, Attention: Investment Grade Syndicate Desk, 3rd Floor, telephone collect at 1-212-834-4533; Truist Securities, Inc., Attention: Prospectus Department, 303 Peachtree Street, Atlanta, GA 30308, telephone: 800-685-4786, or e-mail: [email protected] ; or U.S. Bancorp Investments, Inc., Attention: High Grade Syndicate, 214 North Tryon Street, 26th Floor, Charlotte, NC 28202, or by telephone at: (877) 558-2607. Electronic copies of these documents are also available from the Securities and Exchange Commission's website at www.sec.gov . This press release is neither an offer to purchase nor a solicitation of an offer to sell the notes, nor shall it constitute an offer, solicitation or sale in any state or jurisdiction in which such offer, solicitation or sale is unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. About Cousins Properties Cousins Properties is a fully integrated, self-administered and self-managed real estate investment trust ("REIT"). The Company, based in Atlanta, GA and acting through the Operating Partnership, primarily invests in Class A office buildings located in high growth Sun Belt markets. Founded in 1958, Cousins creates shareholder value through its extensive expertise in the development, acquisition, leasing, and management of high-quality real estate assets. The Company has a comprehensive strategy in place based on a simple platform, trophy assets, and opportunistic investments. Forward-Looking Statements Certain matters contained in this press release are "forward-looking statements" within the meaning of the federal securities laws and are subject to uncertainties and risks, as itemized in Item 1A included in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 and in the Company's Quarterly Reports on Form 10-Q for the quarters ended June 30, 2024 and September 30, 2024 . These forward-looking statements include information about the Company's possible or assumed future results of the business and the Company's financial condition, liquidity, results of operations, plans, and objectives. They also include, among other things, statements regarding subjects that are forward-looking by their nature, such as: guidance and underlying assumptions; business and financial strategy; future debt financings; future acquisitions and dispositions of operating assets or joint venture interests; future acquisitions and dispositions of land, including ground leases; future acquisitions of investments in real estate debt; future development and redevelopment opportunities; future issuances and repurchases of common stock, limited partnership units, or preferred stock; future distributions; projected capital expenditures; market and industry trends; future occupancy or volume and velocity of leasing activity; entry into new markets, changes in existing market concentrations, or exits from existing markets; future changes in interest rates and liquidity of capital markets; and all statements that address operating performance, events, investments, or developments that we expect or anticipate will occur in the future — including statements relating to creating value for stockholders. Any forward-looking statements are based upon management's beliefs, assumptions, and expectations of our future performance, taking into account information that is currently available. These beliefs, assumptions, and expectations may change as a result of possible events or factors, not all of which are known. If a change occurs, our business, financial condition, liquidity, and results of operations may vary materially from those expressed in forward-looking statements. Actual results may vary from forward-looking statements due to, but not limited to, the following: the availability and terms of capital and our ability to obtain and maintain financing arrangements on terms favorable to us or at all; the ability to refinance or repay indebtedness as it matures; any changes to our credit rating; the failure of purchase, sale, or other contracts to ultimately close; the failure to achieve anticipated benefits from acquisitions, developments, investments, or dispositions; the effect of common stock or operating partnership unit issuances, including those undertaken on a forward basis, which may negatively affect the market price of our common stock; the availability of buyers and pricing with respect to the disposition of assets; changes in national and local economic conditions, the real estate industry, and the commercial real estate markets in which we operate (including supply and demand changes), particularly in Atlanta , Austin , Tampa , Charlotte , Phoenix , Dallas , and Nashville , including the impact of high unemployment, volatility in the public equity and debt markets, and international economic and other conditions; threatened terrorist attacks or sociopolitical unrest such as political instability, civil unrest, armed hostilities, or political activism, which may result in a disruption of day-to-day building operations; changes to our strategy in regard to our real estate assets may require impairment to be recognized; leasing risks, including the ability to obtain new tenants or renew expiring tenants, the ability to lease newly-developed and/or recently acquired space, the failure of a tenant to commence or complete tenant improvements on schedule or to occupy leased space, and the risk of declining leasing rates; changes in the preferences of our tenants brought about by the desire for co-working arrangements, trends toward utilizing less office space per employee, and the effect of employees working remotely; any adverse change in the financial condition or liquidity of one or more of our tenants or borrowers under our real estate debt investments; volatility in interest rates (including the impact upon the effectiveness of forward interest rate contract arrangements) and insurance rates; inflation; competition from other developers or investors; the risks associated with real estate developments (such as zoning approval, receipt of required permits, construction delays, cost overruns, and leasing risk); supply chain disruptions, labor shortages, and increased construction costs; risks associated with security breaches through cyberattacks, cyber intrusions or otherwise, as well as other significant disruptions of our information technology networks and related systems, which support our operations and our buildings; changes in senior management, changes in the Company's board of directors, and the loss of key personnel; the potential liability for uninsured losses, condemnation, or environmental issues; the potential liability for a failure to meet regulatory requirements, including the Americans with Disabilities Act and similar laws or the impact of any investigation regarding the same; the financial condition and liquidity of, or disputes with, joint venture partners; any failure to comply with debt covenants under debt instruments and credit agreements; any failure to continue to qualify for taxation as a real estate investment trust or meet regulatory requirements; potential changes to state, local, or federal regulations applicable to our business; material changes in dividend rates on common shares or other securities or the ability to pay those dividends; potential changes to the tax laws impacting real estate investment trusts and real estate in general; risks associated with climate change and severe weather events, as well as the regulatory efforts intended to reduce the effects of climate changes and investor and public perception of our efforts to respond to the same; the impact of newly adopted accounting principles on our accounting policies and on period-to-period comparisons of financial results; risks associated with possible federal, state, local, or property tax audits; and those additional risks and environmental or other factors discussed in reports filed with the Securities and Exchange Commission by the Company. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company cannot guarantee the accuracy of any such forward-looking statements contained in this press release, and the Company does not intend to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Contacts Roni Imbeaux Vice President, Finance and Investor Relations 404-407-1104 [email protected] SOURCE Cousins PropertiesANDOVER, Mass. , Dec. 2, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the appointment of Mr. Gerardo Hernandez as the Company's Chief Financial Officer, effective December 2, 2024 . In this role, Mr. Hernandez joins the TransMedics executive leadership team, succeeding Mr. Stephen Gordon . To enable a smooth transition, Mr. Gordon will remain a non-executive employee of the Company until March 31, 2025 , before serving as a non-employee senior advisor to the Company focusing on national transplant stakeholder engagement until March 31, 2026 . TransMedics also updated its 2024 financial outlook. Dr. Waleed Hassanein , Mr. Gerardo Hernandez and Mr. Stephen Gordon will attend the upcoming Piper Sandler Conference on December 3, 2024 , the TransMedics Investor & Analyst Day on December 10, 2024 , as well as the J.P. Morgan Healthcare Conference in January 2025 . Mr. Hernandez is an accomplished finance leader with over 25 years of experience across the healthcare and consumer packaged goods (CPG) sectors. He most recently served as Vice President Finance, Head of Corporate Financial Planning and Analysis at Alnylam Pharmaceuticals, a biopharmaceutical company focused on RNAi therapeutics. In this role, Mr. Hernandez led a global team as the company scaled rapidly. Prior to his role at Alnylam, Mr. Hernandez spent nearly a decade at Shire, where he rose through the organization, eventually leading corporate FP&A. During his tenure, Shire was acquired by Takeda in a $62 billion transaction, after which he was instrumental in the integration effort. Mr. Hernandez began his career at Unilever where he held several finance roles of increasing responsibility before joining Shire in 2010. Mr. Hernandez holds a Bachelor of Science degree in Finance from the University of Wisconsin , La Crosse and an MBA in Strategy and Economics from Fundação Getulio Vargas , Sao Paulo, Brazil . "Stephen has been an exceptional partner to me as a member of the TransMedics leadership team for nearly a decade. During his tenure we transitioned the Company from a clinical stage organization to a high growth, publicly traded commercial business," said Waleed Hassanein , M.D., President and Chief Executive Officer. "On behalf of the entire management team and the Board, I want to thank Stephen for his countless contributions to our business that will have lasting benefits for the Company. I am grateful for Stephen's dedication and efforts to advance our corporate strategy while delivering considerable shareholder value, and I look forward to his continued partnership to affect a smooth transition as we start our next chapter at TransMedics." "I am delighted to welcome Gerardo to the TransMedics leadership team as our new Chief Financial Officer," added Dr. Hassanein. "His proven record over two decades of leadership across FP&A functions within high-growth, complex global organizations makes him an ideal addition to our team. I am looking forward to partnering with Gerardo as we continue to deliver significant long-term corporate growth and shareholder value." "I am thrilled to join TransMedics as Chief Financial Officer," said Mr. Hernandez. "I look forward to working with the entire leadership team to expand access to the Company's unparalleled products and services in the organ transplant field while enhancing operational efficiency and delivering lasting value to both our shareholders and the patients we serve." Dr. Hassanein concluded, "As we enter the final weeks of the fourth quarter, we are also updating our financial outlook for the full year 2024. Our updated guidance reflects our continued expectation for considerable year-over-year revenue growth. We look forward to providing additional context at our upcoming Investor & Analyst Day." 2024 Financial Outlook TransMedics now expects revenue for the full year 2024 to be in the range of $428 million to $432 million, which represents 77% to 79% growth compared to the Company's prior year revenue. Piper Sandler 36th Annual Healthcare Conference Members of the TransMedics management team will participate in a fireside chat at the upcoming Piper Sandler 36th Annual Healthcare Conference at the Lotte New York Palace. The fireside chat will take place on Tuesday, December 3, 2024 , at 4:00 p.m. Eastern Time . A live and archived webcast of the fireside chat will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com . The Company's standard investor presentation is also available through this link. TransMedics Investor & Analyst Day Details TransMedics will discuss the transition and updated financial outlook, as well as the Company's growth strategy, clinical pipeline, and operations, in greater detail at its Investor & Analyst Day in New York City on Tuesday, December 10, 2024 , at 10:00 a.m. Eastern Time . A live and archived webcast of presentations and Q&A sessions will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com . Please note management will only take questions from the live audience during the question-and-answer session following formal presentations. About TransMedics Group, Inc. TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts , the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure. Forward-Looking Statements This press release contains forward-looking statements with respect to, among other things, a leadership transition and our full-year guidance. For this purpose, all statements other than statements of historical facts are forward-looking statements. The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect," "should," "could," "target," "predict," "seek" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are subject to a number of risks and uncertainties. Our management cannot predict all risks, nor can we assess the impact of all factors or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in or implied by any forward-looking statements we may make. In light of these risks and uncertainties, the forward-looking events and circumstances discussed in this press release may not occur and actual results could differ materially and adversely from those anticipated in or implied by the forward-looking statements. Some of the key factors that could cause actual results to differ include: our ability to maintain profitability on a sustained basis; our ability to attract, train and retain key personnel; our existing and any future indebtedness, including our ability to comply with affirmative and negative covenants under our credit agreement to which we will remain subject until maturity; the fluctuation of our financial results from quarter to quarter; our need to raise additional funding and our ability to obtain it on favorable terms, or at all; our ability to use net operating losses and research and development credit carryforwards; our dependence on the success of the Organ Care System or OCS; our ability to expand access to the OCS through our National OCS Program or NOP; our ability to scale our manufacturing and sterilization capabilities to meet increasing demand for our products; the rate and degree of market acceptance of the OCS; our ability to educate patients, surgeons, transplant centers and private and public payors on the benefits offered by the OCS; our ability to improve the OCS platform and develop the next generation of the OCS products; our dependence on a limited number of customers for a significant portion of our revenue; our ability to maintain regulatory approvals or clearances for our OCS products in the United States , the European Union, and other select jurisdictions worldwide; our ability to adequately respond to the Food and Drug Administration or FDA, or other competent authorities, follow-up inquiries in a timely manner; the performance of our third-party suppliers and manufacturers; our use of third parties to transport donor organs and medical personnel for our NOP and our ability to maintain and grow our logistics capabilities to support our NOP and reduce dependence on third party transportation, including by means of attracting, training and retaining pilots, and the acquisition, maintenance or replacement of fixed-wing aircraft for our aviation transportation services or other acquisitions, joint ventures or strategic investments; our ability to maintain Federal Aviation Administration or FAA or other regulatory licenses or approvals for our aircraft transportation services; price increases of the components of our products and maintenance, parts and fuel for our aircraft; the timing or results of post-approval studies and any clinical trials for the OCS; our manufacturing, sales, marketing and clinical support capabilities and strategy; attacks against our information technology infrastructure; the economic, political and other risks associated with our foreign operations; our ability to protect, defend, maintain and enforce our intellectual property rights relating to the OCS and avoid allegations that our products infringe, misappropriate or otherwise violate the intellectual property rights of third parties; the pricing of the OCS, as well as the reimbursement coverage for the OCS in the United States and internationally; regulatory developments in the United States, European Union and other jurisdictions; the extent and success of competing products or procedures that are or may become available; our ability to service our 1.50% convertible senior notes, due 2028; the impact of any product recalls or improper use of our products; our estimates regarding revenues, expenses and needs for additional financing; and other factors that may be described in our filings with the Securities and Exchange Commission (the "SEC"). Additional information will be made available in our annual and quarterly reports and other filings that we make with the SEC. The forward-looking statements in this press release speak only as of the date of this press release. Factors or events that could cause our actual results to differ may emerge from time to time, and we are not able to predict all of them. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by applicable law. Investor Contact: Brian Johnston Laine Morgan 332-895-3222 Investors@transmedics.com View original content to download multimedia: https://www.prnewswire.com/news-releases/transmedics-appoints-gerardo-hernandez-as-chief-financial-officer-and-provides-updated-2024-financial-outlook-302320060.html SOURCE TransMedics Group, Inc.

With NFL games on Wednesday, Thursday and Saturday this week, Week 17's Sunday slate only features nine games. With several games like Raiders vs. Saints where both teams are bad, putting money on the traditional betting line is challenging. But it is a great week for NFL player props. The following are our top 10 player prop picks for Sunday's NFL games. (Odds are from FanDuel unless otherwise indicated.) Jets vs. Bills --Breece Hall, O/U 49.5 Rushing Yards at -113/-113 Hall has gone over this number in six of his last seven games. With rain in the forecast for Buffalo on Sunday, there is a good chance the Jets will focus more on the run. Plus, the more they run, the longer they can keep Josh Allen on the sideline. Hall ran for a season-high 113 yards on the Bills earlier this year. The Bills have been an average run defense this season, which makes me think Hall will easily surpass 49.5 yards. Take the OVER. --James Cook, O/U 77.5 Rushing + Receiving Yards at -114/-114 The Bills have leaned into the run the last couple of weeks, with Cook going for 100-plus in two straight games and three of four. With inclement conditions expected, it would be surprising if they didn't hand off to Cook early and often this week as well. He could go over the total just running the ball. But in case he doesn't break off a long run like he did the last two weeks, he'll make up the difference with a couple of screen passes. Take the OVER. Falcons vs. Commanders --Bijan Robinson, O/U 83.5 Rushing Yards at -113/-113 --Robinson, O/U 18.5 Rushing Attempts at -132/+102 The best thing Atlanta can do to help Michael Penix Jr. is establish the run, which the Falcons should do anyway with a running back like Robinson. He's gone for 86 or more yards in six of his last seven games (four in a row). He carried the ball 19-plus times in each of them; in the outlier, he only had 12 carries. Atlanta will make sure Robinson eats against Washington's lackluster run defense (29th in the NFL). Take the OVER on both. --Michael Penix Jr., O/U 207.5 Passing Yards at -114/-114 --Penix, O/U 29.5 Pass Attempts The Falcons will try to protect their rookie this week, much like they did last week vs. the Giants. Establishing the run will be the focus of the offense, with enough passing to keep the Commanders' defense (which happens to be one of the best pass defenses in the league) honest. Penix had 27 pass attempts last week. Teams have been attempting 28.5 per game on the Commanders this season and 32.3 in the last three. If Cousins was still at QB, I'd expect Atlanta to be closer to 32 attempts than 28 -- but not Penix. They'll play it safe with Penix again. Take the UNDER for both. Dolphins vs. Browns --Tyreek Hill, O/U 49.5 Receiving Yards at -114/-114 It hasn't been the kind of year we've come to expect from Hill, but with all the injury issues Miami has dealt with, it's not surprising. He's averaging 55.6 yards per game this season and has exceeded 49.5 yards in three of his last six games. But the Dolphins are still alive for the playoffs and are facing a Browns defense giving up 157.7 yards per game to wide receivers this season. Other pass-happy teams like the Broncos (Week 13) and Bengals (Week 16) saw their wide receivers combine for 200-plus. Take the OVER. Giants vs. Colts --Jonathan Taylor, O/U 102.5 Rushing Yards at -115/-115 (via DraftKings) --Taylor O/U 22.5 Rushing Attempts at -110/-110 (via DraftKings) Taylor carried the ball 29 times for 218 yards last week vs. Tennessee, but 135 yards came on two carries. Expecting similar numbers would be unrealistic. But as long as the Colts decide to abuse the Giants' 31st-ranked run defense rather than (try to) establish the pass, good things will happen. Taylor has had at least 21 attempts each time the Colts have won while he was healthy this season. As bad as the Giants' run defense is, it makes sense to feed Taylor the ball 25 times. Take the OVER for both. Cowboys vs. Eagles --Saquon Barkley, O/U 111.5 Rushing Yards at -113/-113 With Jalen Hurts out this week, the Eagles will likely focus on establishing the run with Barkley to take pressure off Kenny Pickett. It didn't result in a win last week against the Commanders, but Washington is a better team than the Cowboys this year. Dallas has held teams to an average of 89.3 yards over their last three games. But the Eagles are playing at home and have a chance to lock up the division with a win. With Barkley and the defense leading the way, they'll get the job done. Take the OVER. --Field Level MediaNASA probe to make history with closest-ever approach to the Sun

A TEENAGER underwent agonising surgery and is on a liquid diet after her jaw snapped in two places when she had an iconic children's sweet. Javeria Wasim and her friend bought two gobstopper sweets, also known aptly as jawbreakers when out shopping in Toronto last month. 6 Javeria Wasim and her friend bought the biggest gobstoppers they could find Credit: Kennedy News 6 After trying to bite through the sweet, Wasim was left with her jaw wired shut for six weeks Credit: Kennedy News 6 The student knew something was wrong when she couldn't open her mouth properly Credit: Kennedy News The pair went back to their university dorm room where 19-year-old Wasim decided to try and bite through the three-inch diameter ball to get to the centre. Usually, you have to keep licking gobstoppers until you reach the middle where there is a gumball sweet. But, Wasim never got that far as she suddenly felt pain in her jaw and her friend pointed out that her front tooth had been chipped and another was loose. The Uni student quickly discovered why the sweets have the name Jawbreaker. read more on surgeries HOME AGAIN Max George discharged from hospital in time for Xmas after emergency surgery BRAVE STAR Davina McCall reveals scar after brain surgery as partner Michael cuts her hair After being taken to the hospital for an X-ray and CT scan, Wasim was told she had fractured her jaw in two places. She was "shocked" at the damage caused by the sweet with doctors telling her that her tooth was "wiggly" because it was on top of the bone that had split apart. The teenager could barely open her mouth and now has her mouth wired shut as it heals. "It hurt really bad, I was crying a lot when the ambulance came and everything was blurry," she said. Most read in The Sun REFFIN' HELL KMI panel reveals FIVE more VAR blunders including THREE mistakes in one game ON PAR Ex-Rangers star 'in line' to take charge of his last club's bitter rivals TRAGIC LOSS Olympic snowboarder Sophie Hediger dead aged 26 after being caught in avalanche IN THE DOCK Suspect appears in court charged with murder of man near Scots nightclub "They told me my jaw is broken and needs to be wired shut. "I was shocked, I thought my biggest problem was my broken tooth." Davina McCall reveals her scar after brain tumour surgery as boyfriend Michael Douglas cuts her hair Wasim underwent an hour-long surgery the day after the incident where her jaw was re-set and a bar was inserted in her top and bottom gums. "The first week of surgery I was in so much pain, I can't explain it. I would just lay in bed and take painkillers," the teen said. "I'd sleep because the only time I wasn't in pain was when I was sleeping." During the six-week healing period, Wasim was on a liquid-only diet. "I can't eat anything, all I'm having are protein shakes and soups, I've lost seven pounds in two weeks," she said. "I haven't eaten in 42 days, I have soup but you're never full, you're always hungry. "All I can think about is how hungry I am, I took the feeling of being full for granted. I miss food so much." "I also feel irritated all the time...You realise how important your mouth is, you use it for literally everything in your life. It has affected my life so much," she added. The business student has said that she has been left "traumatised" by what happened and that she will "probably never try a jawbreaker again." When she and her friend bought the sweets, they wanted to buy "the biggest size they had." "I said we have to break it because people lick their way through it and it takes them months to get through it all," Wasim recalled. "It was such a stupid thing, people break their jaws in car accidents and fights, this was such an avoidable way to break your jaw. Read more on the Scottish Sun SHOCK SWOOP Former Celtic boss 'lines up shock January transfer swoop for Kyogo Furuhashi' MAKE THE YULETIDE GREY White Christmas update for Scots as snow & 80mph winds wreak chaos "I'd tell people if they want to get in the middle of a jawbreaker, it's better to take the six weeks to get through to it than having six weeks suffering the consequences of biting it and having your jaw wired shut." Wasim had her jaw unwired on Monday but she will need braces to fix her teeth after the incident left all of her bottom teeth "messed up." 6 Two bars were inserted into her gums after her jaw was reset Credit: Kennedy News 6 Wasim says she has been left 'traumatized' by the ordeal Credit: Kennedy News 6 Wasim believes that she has now been turned off jawbreakers for life Credit: Kennedy News